To gain clinical insight regarding how RARRES1 silencing influences the dissemination of malignant cells, expression was quantified between primary breast tumors and their corresponding metastatic lymph nodes (total 6 cases examined, Tables S2 and S4) by employing IHC staining using a RARRES1-specific antibody. This evidence concerns the gene RARRES1 and breast neoplasm.